RO5424802

· Hoffmann-La Roche

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for RO5424802, covering 2016-10-18 to 2016-11-02. Get the full timeline:

Most recent: Clinical Trial Update: A Study of the Elimination, Pharmacokinetics, and Metabolism of RO5424802 [Phase 1]